Overview

Description

  • NatureSynthetic

Associated products

Specifications

Our Abpromise guarantee covers the use of ab25851 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking

  • FormLiquid
  • Additional notes

    - First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
    - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
    - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
    - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
    - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    Information available upon request.

General Info

  • Alternative names
    • CARD adapter inducing interferon beta
    • CARD adaptor inducing IFN beta
    • Cardif
    • DKFZp666M015
    • FLJ27482
    • FLJ41962
    • IFN B promoter stimulator 1
    • Interferon beta promoter stimulator protein 1
    • Ips 1
    • IPS-1
    • Ips1
    • KIAA1271
    • MAVS
    • MAVS_HUMAN
    • Mitochondrial anti viral signaling protein
    • Mitochondrial Antiviral Signaling
    • Mitochondrial antiviral signaling protein
    • Mitochondrial antiviral-signaling protein
    • Putative NF kappa B activating protein 031N
    • Putative NF-kappa-B-activating protein 031N
    • Virus induced signaling adapter
    • virus induced signaling adaptor
    • Virus-induced-signaling adapter
    • VISA
    see all
  • FunctionRequired for innate immune defense against viruses. Acts downstream of DDX58 and IFIH1/MDA5, which detect intracellular dsRNA produced during viral replication, to coordinate pathways leading to the activation of NF-kappa-B, IRF3 and IRF7, and to the subsequent induction of antiviral cytokines such as IFN-beta and RANTES (CCL5). May activate the same pathways following detection of extracellular dsRNA by TLR3. May protect cells from apoptosis.
  • Tissue specificityPresent in T-cells, monocytes, epithelial cells and hepatocytes (at protein level). Ubiquitously expressed, with highest levels in heart, skeletal muscle, liver, placenta and peripheral blood leukocytes.
  • Sequence similaritiesContains 1 CARD domain.
  • DomainBoth CARD and transmembrane domains are essential for antiviral function. The CARD domain is responsible for interaction with DDX58 and IFIH1.
  • Post-translational
    modifications
    Ubiquitinated; undergoes 'Lys-48'-linked polyubiquitination catalyzed by ITCH; ITCH-dependent polyubiquitination is mediated by the interaction with PCBP2 and leads to MAVS proteasomal degradation.
  • Cellular localizationMitochondrion outer membrane.
  • Information by UniProt

References for Human MAVS peptide (ab25851)

ab25851 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab25851.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"